Edition:
United Kingdom

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

4.85USD
4:50pm GMT
Change (% chg)

$0.10 (+2.11%)
Prev Close
$4.75
Open
$4.80
Day's High
$4.95
Day's Low
$4.75
Volume
18,877
Avg. Vol
67,813
52-wk High
$8.25
52-wk Low
$2.35

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. 2.43 290.75 45.62
P/E Low - Last 5 Yrs. 2.43 93.66 24.34
Beta 0.72 0.85 0.88
Price to Sales (TTM) 21.99 100.67 5.40
Price to Book (MRQ) 4.27 13.50 5.38
Price to Tangible Book (MRQ) 4.12 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg 0.00 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 48.46 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 50.63 75.03 5.38
Sales - 5 Yr. Growth Rate 7.06 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 3.80 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -190.00 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -8.03 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 5.73 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -4.05 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -133.15 -- --
EBITD - 5 Yr. Avg -56.72 -261.11 15.24
Operating Margin (TTM) -136.21 -556.64 7.76
Operating Margin - 5 Yr. Avg. -11.37 -279.29 10.75
Pre-Tax Margin (TTM) -195.19 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -17.83 -279.02 11.17
Net Profit Margin (TTM) -195.19 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -17.83 -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,314,503 864,673,362
Net Income/Employee (TTM) -- 3,332,048 101,717,513
Receivable Turnover (TTM) 5.89 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.21 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.46 -0.78 11.00
Return on Assets - 5 Yr. Avg. -8.26 -0.26 12.43
Return on Investment (TTM) -51.57 2.35 14.46
Return on Investment - 5 Yr. Avg. -10.81 2.98 16.28
Return on Equity (TTM) -55.72 2.95 16.05
Return on Equity - 5 Yr. Avg. -11.20 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 9.63 -9.30 7.06
EPS (TTM) % -144.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arbutus Biopharma Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -23.10 -23.46 6 53
13 Week 42.41 37.58 88 61
26 Week 3.98 7.32 63 69
52 Week 9.02 2.39 58 46
YTD 29.26 24.97 68 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.